Please note: AABB reserves the right to make updates to this program.
Live Program Date: Thursday, November 8, 2018 -
Master Program Number: 18EL-378 (see program format numbers below under Registration)
Educational Track: Technical/Clinical
Topic: Patient Blood Management
Intended Audience: Director, Hospitals, Hospital Blood Bank, Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Perfusionists, Physicians, Resident/Fellow, Technologists, Transfusion Safety Officer
Teaching Level: Intermediate to Advanced
Director/Moderator: Kathy Puca, MD, Medical Director, BloodCenter of Wisconsin, Milwaukee, WI
Speakers: Ehab Atallah, MD, Associate Professor of Medicine, Medical College of Wisconsin, Milwaukee, WI; Mary Fournogerakis, Froedtert Hospital, Milwaukee, WI; Tina Curtis, Executive Director, Cancer Services, Froedtert Hospital, Milwaukee, WI
After participating in this educational activity, participants should be able to:
- Identify the challenges in blood management for the oncology patient
- Discuss current evidence to guide RBC transfusion practice in oncology patients
- Describe any strategies for improving RBC or platelet utilization in oncology patients
The growing number of patients with cancer and the care and treatment of such patients presents unique challenges for better utilization of blood products. Anemia and thrombocytopenia are common side effects of chemotherapy treatment in oncology patients which can lead to the need for red cell and platelet transfusions. These hematological disorders and treatment regimens can significantly impact the mortality, morbidity, and quality of life for the patient. In this program, the etiologies of anemia and thrombocytopenia in oncology patients and how it differs from medical patients will be discussed as well as potential patient blood management strategies to improve blood utilization in this unique patient population.
| || ||
|Single Viewer: On-Demand||
|Group Viewing: On-Demand||
Continuing Education Credit
AABB designates both the live and on-demand version of this eCast each to be eligible for 1.0 continuing education credit/contact hour for Physicians, California Nurse, California Lab Personnel, Florida Lab Personnel and General Participation credit. The final number of credit(s) and credit types awarded for this program (live or on-demand) was determined by the program duration. For more information on each credit type please visit our
Continuing Education Credits webpage.
Dr. Ehab Atallah is Associate Professor of Medicine at the Medical College of Wisconsin Division of Hematology and Oncology, specializing in leukemia and myelodysplastic syndromes at Froedtert Hospital. He graduated from Cairo University School of Medicine in 1994, then completed an internal medicine residency in the Cleveland Clinic Health System and a fellowship in hematology/oncology at the Karmanos Cancer Center in Detroit, Michigan, where he also served as Chief Fellow. He then went on to complete a leukemia fellowship at M.D. Anderson Cancer Center in Houston, Texas. Dr. Atallah is board certified in Internal Medicine, Medical Oncology, and Hematology. He has authored numerous publications, including journal articles, meeting abstracts, and a book chapter. In 2007, he received the American Society of Clinical Oncology Foundation Merit Award. His current research interests are treatment of patients with leukemia, myeloproliferative neoplasms and myelodysplastic syndromes.
Tina Curtis, DNP, MBA, RN, NEA-BC has held a variety of progressive nursing leadership roles over the past ten years. She currently serves as the Executive Director for Cancer Services at Froedtert & the Medical College of Wisconsin Clinical Cancer Center. She is responsible for strategic planning, clinical performance, and overall daily operations of the Cancer Service Line. Tina is certified as a Nurse Executive - Advanced, and holds a MSN, MBA, and a Doctorate in Nursing Practice in executive leadership from Marquette University in Milwaukee, Wisconsin.